Search Orphan Drug Designations and Approvals
-
Generic Name: | N-(bromoacetyl)-3,3-dinitroazetidine |
---|---|
Date Designated: | 06/15/2017 |
Orphan Designation: | Treatment of neuroendocrine tumors |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
EpicentRx, Inc. 4445 Eastgate Mall Suite 200 San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-